BERGENBIO
BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers.
BERGENBIO
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2007-01-01
Address:
Bergen, Hordaland, Norway
Country:
Norway
Website Url:
http://www.bergenbio.com
Total Employee:
11+
Status:
Active
Total Funding:
183.44 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro ReCAPTCHA Cloudflare JS CDN JS ReCAPTCHA V2 Amazon Virginia Region CloudFront Amazon S3 CDN
Similar Organizations
Advaxis
Advaxis is a developer of multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Anjarium Biosciences
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
Inthera Bioscience
Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company.
Numeric Biotech
Numeric Biotech is to build an innovative portfolio of first-in-class treatments that target multiple mechanisms of age related diseases.
OCTIMET Oncology
OCTIMET has licensed from Janssen Pharmaceutica, highly selective MET kinase inhibitors with clean safety profiles
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Oncopeptides
Oncopeptides AB is a privately held clinical stage company developing melflufen, a peptidase potentiated therapy for multiple myeloma.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Meteva AS
Meteva AS investment in Post-IPO Debt - BerGenBio
Investinor
Investinor investment in Series D - BerGenBio
Meteva AS
Meteva AS investment in Series D - BerGenBio
Sarsia Seed Management
Sarsia Seed Management investment in Series C - BerGenBio
Investinor
Investinor investment in Series C - BerGenBio
Investinor
Investinor investment in Series B - BerGenBio
Sarsia Seed Management
Sarsia Seed Management investment in Series A - BerGenBio
Investinor
Investinor investment in Series A - BerGenBio
Sarsia Seed Management
Sarsia Seed Management investment in Seed Round - BerGenBio
Birk Venture
Birk Venture investment in Seed Round - BerGenBio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-11 | BerGenBio strengthens its leadership team with appointment of Cristina Oliva as Chief Medical Officer |
Official Site Inspections
http://www.bergenbio.com Semrush global rank: 10.02 M Semrush visits lastest month: 279
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "BerGenBio"
About - BerGenBio
BerGenBio is leveraging its solid leadership position in understanding the role of AXL to develop a new therapeutic approach for lung cancer patients. Partnerships based on BerGenBio’s …See details»
BerGenBio - Crunchbase Company Profile & Funding
BerGenBio is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel …See details»
BerGenBio - Developing first-in-class AXL inhibitors for aggressive …
BerGenBio is a clinical-stage biopharmaceutical company developing innovative drugs for aggressive diseases including cancer and severe respiratory infections. Recent News. 26th …See details»
BerGenBio - businessabc
Oct 18, 2024 BerGenBio has been recognized by numerous organizations for its technology, accomplishments, and culture. These include; The Frost & Sullivan 2019 North American …See details»
Corporate presentation May 4 2022 - files.bergenbio.com
May 4, 2022 www.bergenbio.com BerGenBiois a world leader in exploring AXL as a transformative treatment modality for severe diseases Lead program, bemcentinib,dosed in …See details»
Investor relations - BerGenBio
Email: [email protected]. First Name. Last name. E-mail Address. Your Inquiry. Submit. Subscribe to our news. Please remember to confirm your email by clicking on the link provided …See details»
BERGENBIO LIMITED Company Profile - Dun & Bradstreet
Bergenbio limited. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / oxford / …See details»
Bergenbio ASA Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Bergenbio ASA of BERGEN, VESTLAND. Get the latest business insights from Dun & Bradstreet. …See details»
BerGenBio ASA (LON: 0RU5) Company Profile & Overview - Stock …
6 days ago BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases …See details»
BerGenBio ASA - Overview, News & Similar companies - ZoomInfo
Who is BerGenBio ASA. BerGenBio is a clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential cornerstone of ther apy for …See details»
BerGenBio - VentureRadar
" BerGenBio is a clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential cornerstone of therapy for aggressive diseases, including …See details»
BerGenBio Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 BerGenBio is an oncology biotech company that develops medicines to treat cancer. The Company develops immuno-oncology drugs, inhibitors, and therapeutics. It also …See details»
BerGenBio - Contacts, Employees, Board Members, Advisors
Organization. BerGenBio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... BerGenBio has 3 board members and …See details»
BerGenBio Annual Report 2021
BerGenBio (OSE:BGBIO) is a clinical stage biopharmaceutical company developing innovative drugs for aggressive diseases including cancer and severe respiratory infections. Initiated new …See details»
Bergenbio ASA, BGBIO:OSL profile - FT.com - Financial Times
Dec 6, 2024 Bergenbio ASA is a Norway-based clinical-stage biopharmaceutical company focused on developing drugs for aggressive diseases including cancer and severe respiratory …See details»
BerGenBio Announces First Patient Entered Into Advanced …
1 day ago BerGenBio is a clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential cornerstone of therapy for aggressive …See details»
BerGenBio Announces First Patient Entered Into Advanced …
1 day ago BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer announced …See details»
Board of Directors - BerGenBio
BerGenBio’s Board of Directors is composed of experienced biopharmaceutical executives with experience of developing next generation cancer drugs and building world class innovative …See details»
BerGenBio Announces First Patient Entered Into Advanced …
1 day ago About BerGenBio ASA. BerGenBio is a clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential cornerstone of …See details»
BerGenBio ASA Statistics - Stock Analysis
6 days ago BerGenBio ASA has a market cap or net worth of GBP 26.86 million. The enterprise value is 14.45 million. Market Cap: 26.86M: Enterprise Value : 14.45M: Important Dates. The …See details»